Here are relevant reports on : stem-cell-therapy-market
-
Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) & Region - Global Forecasts to 2024
The cardiac resynchronization therapy market is projected to reach USD 5.1 billion by 2024, at a CAGR of 4.4%. The growth of the Cardiac Resynchronization Therapy Market is majorly driven by the increasing incidence of target diseases (primarily due to the rising geriatric population). Rising investments and support, along with technological advancements, are also contributing to the growth of this market. Prominent players in the Cardiac Resynchronization Therapy Market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Induced Pluripotent Stem Cells Market - Global Forecasts to 2023
The global Induced Pluripotent Stem Cells Market is estimated to be valued at USD 1,245.0 million in 2017 and is projected to reach 1,829.3 million by 2023 at a rate of 8.0%. The iPSC market is broadly segmented into hepatocytes, fibroblasts, keratinocytes, amniotic cells, and other cell types. The global induced pluripotent stem cells market is developing rapidly. The primary reason for inclination toward usage of induced pluripotent stem cells is their ability to make any cell or tissue required by the body to defend or combat diseases such as leukemia, spinal cord injury, heart disease, and diabetes. Another advantage is that iPSCs can be created from the tissue of the same patient that will receive the transplantation, thus avoiding immune rejection. Other factors supporting the growth of the market are the increased research funding, growth in number of genomics projects, and increasing use of genome engineering in personalized medicine. However, adverse public of genetic research is likely to restrain the growth of the market.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) - Global Forecast to 2028
The global particle therapy market, valued at US$0.6 billion in 2022, stood at US$0.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.2% from 2023 to 2028, culminating in a forecasted valuation of US$1.1 billion by the end of the period. Many factors, such as technological advancements, funding and reimbursement, strong healthcare funding, active research funding, a clear regulatory framework, growing minimally invasive procedure adoption, and the presence of key market players in developing regions are driving the growth of the particle therapy market
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
North American Home Healthcare Market By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017
The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017
The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), End User (Hospitals) & Region - Global Forecasts to 2023
The cell surface markers market is projected to reach USD 769 million by 2023, at a CAGR of 8.1%. Factors such as the increasing funding for life sciences research, high global prevalence of cancer, and growth in stem cell and neurobiology research are expected to drive the growth of this market in the coming years.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Cardiovascular Therapy - Advanced Technologies And Global Market (2012 - 2017)
The research report outlines the latest developments in the cardiovascular therapy industry across the globe. The market data includes innovative technologies, key players, market trends and opportunities, drivers and challenges are clearly identified and examined.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Photodynamic Therapy Market - 2019 By Types, Application & Geography
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Cell Culture Media Market by Type (Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application (Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User (Pharma, Biotech) & Region - Global Forecast to 2028
The global cell culture media market, valued at US$5.5 billion in 2022, stood at US$6.2 billion in 2023 and is projected to advance at a resilient CAGR of 16.0% from 2023 to 2028, culminating in a forecasted valuation of US$13.0 billion by the end of the period. Factors such as the growing focus on personalized medicine, increased investment in stem cell research, increasing demand for serum and animal component-free media and increasing demand for monoclonal antibodies and biosimilars are driving the growth of the cell culture media industry.
- Published: July 2023
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
